(A) tSNE plot of single cells distinguished by cluster annotations. Numbers in brackets on the left indicate organoid quantities used for each condition. Within each condition, organoids (day 77 ~ day 86, see methods for details) were collected from 2 different culture dishes, pooled together, and dissociated for scRNA-seq. For drug treatment, 75 nM JQ1 was supplemented to the media starting from day 25 until the date of sample collection. CN: cortical neuron; IN: interneuron; RGC: radial glia cell; AS: astrocyte; MAS: mature astrocyte; NPC: neural progenitor cell; OPC: oligodendrocyte progenitor cell; iOL: immature oligodendrocyte; OB-like cell: osteoblast-like cell.
(B and C) Gene dysregulation in MeCP2-R133C neuron or glia clusters derived from hMGEOs (B) or hCOs (C) with or without JQ1 treatment. The dysregulation score (= −log10(p-value) by two-side T test comparing MeCP2-WT and MeCP2-R133C cells is plotted.
(D) Expression patterns of representative genes for cell type specification in hMGEO-derived cells. Cell types of each row correspond to the same row delineated in B.
(E) Expression patterns of representative genes for cell type specification in hCO-derived cells. Cell types of each row correspond to the same row delineated in C.
See also Figure S7.